BRK-B vs RVSB
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
RVSB presents as a classic value play, trading significantly below its Graham Number ($6.41) and Intrinsic Value ($6.16) with a Price-to-Book ratio of 0.69. The Piotroski F-Score of 4/9 indicates stable but mediocre financial health, which is corroborated by a very low ROE of 3.01% and ROA of 0.32%. While the company shows positive YoY revenue and earnings growth, the bearish technical trend and poor asset utilization suggest a lack of immediate momentum. The stock is fundamentally undervalued, but the lack of profitability efficiency prevents a bullish rating.
Compare Another Pair
Related Comparisons
BRK-B vs RVSB: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Riverview Bancorp, Inc. (RVSB) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.